Présentation de l'entreprise
Healthcare Realty Trust Incorporated, trading under the ticker HR, functions as a real estate investment trust (REIT) dedicated to the ownership and operation of medical outpatient facilities. These properties are strategically situated in close proximity to leading hospital campuses, serving a specialized niche within the healthcare infrastructure sector. The company operates within the REIT - Healthcare Facilities industry, a classification that defines its business model as a passive investment vehicle focused on stable cash flow from property rentals rather than manufacturing or service provision. In terms of scale, the entity manages a market capitalization of $6.22B while generating $1.18B in annual revenue and employing 539 individuals across its portfolio. The substantial market capitalization figure indicates that the market assigns significant value to the underlying real estate assets, suggesting confidence in the long-term demand for medical office space. Conversely, the annual revenue of $1.18B reflects the steady income stream derived from leasing these facilities to medical providers, establishing the company as a mid-to-large-sized player within the specialized real estate investment landscape.
Santé financière
The company reported a revenue of $1.18B for the trailing twelve months, yet recorded a net income of $-248,480,992, while maintaining an EBITDA of $703.89M. The significant disparity between the positive EBITDA and the negative net income reveals a cost structure characterized by substantial non-operating expenses, interest obligations, or corporate-level costs that erode the operating profit generated by the properties. Despite the reported net loss, the entity generated a free cash flow of $107.20M, which provides essential financial flexibility to service debt obligations, fund capital expenditures, or pursue strategic acquisitions without relying on external equity financing. The margin analysis highlights a gross margin of 61.8%, indicating efficient property management and rental pricing power before operating expenses, an operating margin of 11.7% which reflects the costs of maintaining medical facilities, and a negative profit margin of -20.8% that underscores the impact of financing costs on the bottom line. The balance sheet shows a cash position of $26.17M against total debt of $4.15B, resulting in a debt-to-equity ratio of 88.77, which indicates a highly leveraged capital structure typical of REITs but requiring careful interest rate management. This leverage is further evidenced by a current ratio of 0.73, suggesting that the company's current assets are insufficient to cover its current liabilities, pointing to a reliance on long-term financing or operating cash flows to meet short-term obligations. Additionally, the return on equity stands at -5.0% and the return on assets is 0.6%, metrics that reveal management has yet to generate positive shareholder returns and is barely covering the cost of capital employed in the assets.
Évaluation de la valorisation
The valuation metrics present a complex picture, with a trailing P/E ratio listed as N/A due to the negative earnings, while the forward P/E is reported as -176.10, implying that the market is currently pricing in a recovery of earnings rather than valuing current profitability. The price-to-book ratio of 1.34 indicates that the market is trading the stock at a 34% premium over its book value, suggesting investors value the quality of the real estate assets or expect future earnings normalization to justify the current price. Alternative valuation measures such as the price-to-sales ratio of 5.27 and the EV/EBITDA of 14.67 provide context by comparing the stock price to revenue and cash flow generation, respectively, which are often more stable indicators for asset-heavy companies like this REIT. The stock has traded within a range defined by a 52-week high of $18.97 and a 52-week low of $14.09, meaning the current price sits below the yearly peak, reflecting recent market volatility or sector-specific headwinds affecting the stock price. The beta value of 0.80 indicates that the stock exhibits lower price volatility than the broader market, suggesting it may be less sensitive to general market fluctuations and offering a more defensive characteristic compared to high-beta equities.
Growth & Income
The financial data shows a revenue growth rate of -7.8% year-over-year, while the earnings growth is N/A due to the negative net income, indicating that the company is currently contracting in revenue and facing profitability challenges rather than expanding. For a dividend payer, the company offers a dividend yield of 5.8% with a payout ratio of 251.5%, which suggests that the dividend distribution is not supported by current earnings and is likely funded by cash flow, reserves, or debt issuance, raising questions about long-term sustainability without an earnings turnaround. Since the earnings growth is not positive, the company is currently unable to reinvest retained earnings into organic growth, and the dividend yield acts as a return to shareholders despite the underlying earnings contraction. Overall, the growth and income profile is characterized by negative revenue expansion and a high, potentially unsustainable dividend payout that does not align with the company's current negative net income position.